Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Simon Paul Fricker"'
Publikováno v:
Journal of Clinical Oncology. 40:TPS9608-TPS9608
TPS9608 Background: Antibodies targeting immune checkpoints such as PD-1 and CTLA-4 has shown significant benefit in late-stage melanoma. But further improvements in therapeutic options are still required. Two approaches for improving the outcome of
Autor:
Simon Paul Fricker
Publikováno v:
Dalton Transactions: An International Journal of Inorganic Chemistry; Oct2007, Vol. 2007 Issue 43, p4903-4917, 15p